# Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/plasma-exchange-and-glucocorticoids-to-delay-death-or-end-stage-renal-disease-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David Jayne,Michael Walsh,Peter A. Merkel,Chen Au Peh,Wladimir Szpirt,Xavier Puéchal,Shouichi Fujimoto,Carmel M. Hawley,Nader Khalidi,Rachel Jones,Oliver Floßmann,Ron Wald,Louis Girard,Adeera Levin,Gina Gregorini,Lorraine Harper,William F. Clark,Christian Pagnoux,Ulrich Specks,Lucy Smyth,Toshiko Ito‐Ihara,Janak de Zoysa,Biljana Brezina,Andrea Mazzetti,Carol A. McAlear,Donna Reidlinger,Samir Mehta,Natalie Ives,Elizabeth Brettell,Hugh Jarrett,Keith Wheatley,Elizabeth Broadhurst,Alina Casian,Charles D. Pusey |
| Citations | 13 |
| DOI | 10.3310/pnxb5040 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://njl-admin.nihr.ac.uk/document/download/2040315 |
| OpenAlex ID | https://openalex.org/W4297260847 |
| PMID | 36155131 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Biljana Brezina](https://scholariq.org/researchers/biljana-brezina/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Paper topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.